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Abstract
Background:  Most fibromyalgia patients are seen in primary care (PC). However, the
effectiveness of the treatments prescribed by general practitioners is usually minimal. The main
objective of the present research is to assess the efficacy of structured psycho-educational
intervention, combined with relaxation, developed to improve the quality of life of patients suffering
fibromyalgia (FM). The second objective is to assess the cost-effectiveness of this multimodal
intervention.
Method/Design: Design. Randomized controlled trial with a 12-month follow-up involving two
groups, one of which is the intervention group that includes patients receiving a psychoeducational
program and the other the control group consisting of patients treated for FM in the usual way.
Setting. Three urban PC centers in the province of Barcelona (Spain).
Sample. The total sample comprises 218 patients (over 18 years of age) suffering FM, selected from
a database (Rheumatology service-Viladecans Hospital) of patients with this illness. Only those
patients introduced in the database between the years 2005 and 2007 were included in the
selection. Selected patients will be asked for written informed consent to participate in the study.
Intervention. Multi-component program including information about the illness, counselling about
physical exercise and training in autogenic relaxation. The intervention consists of nine 2-hour
sessions delivered during a two-month period. The pharmacological treatment prescribed by the
physician was maintained in both groups.
Main variables. Sociodemographic characteristics, quality of life, use and cost of healthcare and
social services.
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Measures. Quality of life is to be measured with the FIQ and the EuroQol-5D, and the use of
healthcare services with an adapted version of the Client Service Receipt Inventory (CSRI). These
variables will be measured before the beginning of the program (baseline) and 1, 2, 6 and 12 months
later.
Discussion:  This research project is an attempt to demonstrate that a psycho-educational
program implemented in the context of PC can produce a significant increase in the quality of life
for patients with FM, as well as a decrease in the use of healthcare and social services, compared
with usual care.
Trial registration: NCT00550966
Background
Fibromyalgia (FM) is a chronic illness of unknown origin
that provokes intense widespread pain and fatigue and
affects people in the biological, psychological and social
dimensions [1-3]. The diagnosis of FM is mainly clinical
and the practitioner takes into account patient history,
physical examination and laboratory evaluations. The
American College of Rheumatology (ACR) established
two major diagnostic criteria in 1990 [4]: first, a history of
widespread pain for at least three months, and second,
patient reporting of tenderness in at least 11 of 18 defined
tender points when digitally palpated with about 4 Kg per
unit area of force. The absence of reliable diagnostic tools
has generated the need for employing subjective scales to
assess the pain and fatigue of these patients [2].
The prevalence of FM in the general population is about
2–4%, and it is nine times more frequent in women than
men [1,3]. In PC consultations the prevalence is about
5–7% [5]. Given its high prevalence and morbidity,
patients suffering FM present an elevated frequency of use
index for healthcare resources.
Although the aetiology of FM is still unknown, it is prob-
ably multifactorial [6-9], which is why multidisciplinary
and biopsychosocial approaches usually obtain better
outcomes than symptomatic treatment alone [10-13]. The
main goal of most treatments is to reduce muscular dys-
function and functional impotence caused by pain.
Among pharmacological treatments, only a minority has
demonstrated significant efficacy. As far as we know, there
is evidence of the efficacy of amitriptyline and cyclobenz-
aprine, whereas studies focused on the efficacy of trama-
dol and selective serotonin re-uptake inhibitors have
yielded only modest evidence [14].
Non-extenuating physical exercise and some relaxation
therapies can also increase pain tolerance, producing a
global improvement in the quality of life of fibromyalgia
patients [15,16]. Gowans et al [16] assessed physical func-
tioning and mood state 6 and 12 months after the begin-
ning of a supervised aerobic physical exercise program.
These authors observed an improvement in participants'
health when the program finished and 6 months later.
Taggart et al [17] reported a satisfactory and significant
increase in the quality of life of fibromyalgic patients after
a 6-week relaxation program.
Another key component in current treatment of FM is the
education of patients concerning their illness [18-20]. The
main objective of educational programs is to increase
skills in coping and healthy behaviour on the part of
patients suffering FM. Scientific evidence has demon-
strated that intensive education programs (between 6 and
17 sessions) improve pain symptoms, fatigue, insomnia
and quality of life. These improvements continue 3 and
12 months later [14]. Furthermore, educational programs
increase patient autonomy, reducing at the same time the
consumption of medicines and use of healthcare services.
The total cost of the continuous use of healthcare services
by FM patients has not been estimated in Spain, but data
from the USA reveal an annual cost of $2,274 per patient.
To date, it has not been demonstrated in Spain whether a
multimodal program, combining autogenic relaxation
and active healthcare education, produces a significant
improvement in the quality of life of patients with FM. In
addition, we do not know whether a multimodal program
is more cost-effective than the treatment usually provided
to these patients.
With this background, then, the main objective of the
present research project will be to determine whether a
multi-component psycho-educational program for treat-
ing FM leads to better quality of life (measured with the
FIQ and the EuroQol-5D) at 1, 2, 6 and 12 months, than
the usual care provided in Catalan Primary Health Care.
The specific aims are to assess the degree of pain perceived
by fibromyalgia patients attending the multimodal pro-
gram, as well as the total direct costs (medication con-
sumption and visits to public or private healthcare
professionals) and indirect (work days lost), and cost-
effectiveness associated with this psychoeducational inter-
vention, compared to usual care.BMC Musculoskeletal Disorders 2008, 9:2 http://www.biomedcentral.com/1471-2474/9/2
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Methods/Design
Design
Controlled trial with a random allocation of participants
in two alternative branches:
1. Implementation of a multimodal psycho-educational
program to improve quality of life in FM (intervention
group).
2. Usual care of FM (control group).
Evaluation of treatment outcomes will be carried out at
the patient level, with individual evaluation at baseline
and 1, 2, 6, and 12 months after the beginning of the
intervention.
Setting and study sample
Three primary health care centres (Viladecans-2, Gavà-1
and Gavà-2) in the province of Barcelona (Catalonia,
Spain) voluntarily participated for the study. The sample
pool (n = 530) comprises only those patients included in
a FM database of the Viladecans Hospital for the years
2005 and 2006. In the event of a lack of participants, the
plan is to recruit patients with FM included in the data-
base during the year 2007.
Patients considered for inclusion will be those aged 18–75
years-old, contactable by telephone, who meet the diag-
nostic criteria of FM established by the ACR. The follow-
ing patients will be excluded: those with a diagnosis not
based on the ACR criteria, those with cognitive impair-
ment or suffering from physical, mental/psychiatric limi-
tations or a severe concurrent rheumatologic illness that
impedes participation in the study evaluations, those who
are not expected to live at least 12 months and those with-
out schooling.
To calculate the sample size it was taken into account that
we need to obtain a difference of at least 5 points in the
FIQ between those that respond and those who are resist-
ant to the intervention. The criterion of 5 points is based
on two previous studies conducted with Spanish fibromy-
algia patients [21,22]. A total of 109 patients per condi-
tion is needed to conduct the study, assuming an alpha
risk of 0.05 and a beta risk of < 0.20 in a bilateral contrast,
a standard error of 12.1 reported in a previous study [21],
and a 15% dropout rate.
Data collection and ethical aspects
First, patients that meet the inclusion criteria will be
phoned by a research assistant who is a psychologist. Sec-
ond, the research assistant will make an appointment
with those patients that agree to participate in the study.
Third, written consent will be obtained before the begin-
ning of the study. Participants will be provided with a gen-
eral overview of the aims and activities of the study. They
will be also informed that they may choose to drop out at
any time with the guarantee that they will continue to
receive the treatment considered most appropriate by
their physician. Patients in the control group will receive
the treatment considered most appropriate by their physi-
cian.
Results will be monitored and most of data collected by
means of standard questionnaires conducted in face-to-
face interview by the research assistant, who has been
trained in the administration of the instruments. The
research assistant does not know which study group the
patients being interviewed belong to ("blind"). Follow-up
assessments shall take place at 1, 2, 6 and 12 months after
the inclusion of the patient (see Table 1).
Variables and instruments of measurement
The study protocol was approved by the research ethics
committee of the Foundation Jordi Gol i Gorina (Barce-
lona) and consists of the following materials:
1.  Sociodemographic characteristics: Gender, birth date,
address, marital status, education level, work status.
2. History of the illness: age of onset, date of the first diag-
nosis, pharmacological treatments (oral antidepressants,
benzodiazepines-hypnotics, muscular relaxants and non-
steroid analgesic and anti-inflammatory medications)
Table 1: Follow-up assessments.
Month 1
• FIQ
• Sociodemographic variables: 1 question (current work situation)
• Pharmacological and non-pharmacological treatment received during 
the last month
Month 2
• FIQ
• Sociodemographic variables: 1 question (current work situation)
• Pharmacological and non-pharmacological treatment received during 
the last month
Month 6
• FIQ
• Sociodemographic variables: 1 question (current work situation)
• Pharmacological and non-pharmacological treatment received during 
the last four months
• CSRI-adapted version: use of healthcare and social services during 
the first six months (0–6 months)
• EuroQoL-5D
Month 12
• FIQ
• Sociodemographic variables: 1 question (current work situation)
• Pharmacological and non-pharmacological treatment received during 
the last six months
• CSRI-adapted version: use of healthcare and social services during 
the first six months (6–12 months)
• EuroQoL-5DBMC Musculoskeletal Disorders 2008, 9:2 http://www.biomedcentral.com/1471-2474/9/2
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and non-pharmacological treatments (physical exercise,
relaxation techniques, cognitive-behavioural therapy)
received during the previous 6 months.
3. Questionnaire on chronic medical condition.
4. Fibromyalgia Impact Questionnaire (FIQ-Spanish version)
[23]: Instrument that measures physical function, work,
and well-being, and contains visual analogue scales (VAS)
for pain, sleep, fatigue, stiffness, anxiety and depression. A
total score may be obtained after normalization of some
items (between 0–10) and adding them to the VAS. Total
scores range between 0–80 (without job items), with a
higher score indicating a negative impact.
5.  EuroQoL-5D questionnaire (EQ-5D – Spanish version)
[22]: Generic instrument of health-related quality of life.
It has two parts: Part 1 records self-reported problems in
each of five domains: mobility, self-care, usual activities,
pain/discomfort and anxiety/depression. Each domain is
divided into three levels of severity corresponding to no
problems, some problems, and extreme problems. Part 2
records the subject's self-assessed health on a Visual Ana-
logue Scale (VAS); it is a vertical 10 cm line on which the
best and worst imaginable health states score 100 and 0,
respectively.
6. Client Service Receipt Inventory – adapted (CSRI – Spanish
version)  [24]: questionnaire for collecting information
about use of healthcare and social care services, other eco-
nomic impacts (such as time off work due to illness) and
socio-demographic information. The variant used in this
study was designed to collect retrospective data on service
utilisation during the first and last six months after the
beginning of the treatment.
Intervention program
Participants from the intervention group will undergo a
multi-component psycho-educational program that deals
with FM based on available scientific evidence. It includes
measures and instruments that can be employed within
the Catalan Primary Health Care, whereas the participants
from the control group will receive only the treatment pre-
scribed by their physician.
The intervention program consists of nine 2-hour sessions
delivered during a two month period. Participants will be
allocated in groups with a maximum of 18 subjects per
group. All sessions will take place at the PC centres Gava-
2 or Viladecans-2. The contents of each session are dis-
played in Table 2.
In order to avoid conversations concerning the psycho-
educational program among patients from different
groups, we will remind the participants from the interven-
tion of the condition that they are not allowed to talk
about the program with those persons that are not attend-
ing their group. Before baseline assessment, an explana-
tory note addressing this important issue will be delivered
to the patients participating in the program.
Forecast execution dates
Initial recruitment of patients: September 2007
Deadline for recruitment of patients: November 2008
Deadline for period of patient monitoring: December
2009
Publication of results: 2010
Statistical analyses
Data collected will be analysed using SAS statistical anal-
ysis software (SAS Institute Inc. 1999. v8.0, 4th ed) and
employing both quantitative and qualitative techniques.
First, the intervention and control groups will be com-
pared in order to verify that there are no significant differ-
ences between them in socio-demographic terms, clinical
baseline data, etc. We shall use mean and standard devia-
tion (SD) in continuous variables and percentages in cat-
egorical variables. For comparisons we shall use the
Student-T test for continuous variables and the Chi-square
test for categorical variables. Non-parametric tests may
also be used.
Given that we have one between-groups factor with two
levels (2 Groups: Intervention and Control) and one
within-subjects factor with five levels (Baseline and 4 fol-
low-up assessments: 0, 1, 2, 6, and 12), a 2 × 5 mixed fac-
torial ANOVA will be performed to study the effect of the
psycho-educational program on the quality of life. Then,
Table 2: Summary of the intervention program.
Session 1: General information. Expectations of the patients. History 
of the illness. Principal and secondary symptoms in FM. Physiological 
mechanisms involved in the genesis of pain.
Session 2: Relaxation training-I
Session 3: Diagnosis. Pharmacological and non-pharmacological 
treatments. Prognosis. Current model of health care in Catalonia. 
Units specialized in the treatment of FM.
Session 4: Relaxation training-II
Session 5: Strategies to increase self-esteem and regulate emotions. 
Pain experience and recurrent invalidation. Social support (family and 
friends).
Session 6: Relaxation training-III
Session 7: Holistic medicine
Session 8: Relaxation training-IV
Session 9: Benefits of physical exercise in FM. Qualitative assessment 
of the intervention program. Resolving doubts. Discussion concerning 
the strengths and weaknesses of the intervention.BMC Musculoskeletal Disorders 2008, 9:2 http://www.biomedcentral.com/1471-2474/9/2
Page 5 of 7
(page number not for citation purposes)
between-subjects planned comparisons may also be used
(post-hoc comparisons with independent samples T-test).
If we observe differences between groups in quality of life
prior to treatment, one-way analyses of covariance will be
carried out using baseline scores as a covariate). In addi-
tion, we shall carry out a logistic regression analysis taking
the groups as dependent variable (the target variable is a
categorical variable with two categories: Intervention and
Control) and the collected measures as independent vari-
ables. This analysis will let us to know the association
between the intervention and the cost of the healthcare
resources, controlling for the rest of variables.
Cost-utility analyses
Societal cost perspective will be used for the calculation of
costs. Direct costs are going to be calculated by adding the
costs derived from any medication and use of health-
related services (general practitioner sessions, specialized
medical sessions, emergency room sessions, and hospital
in-patient stay). The cost of medications will be calculated
by determining the price per milligram during the study,
according to the International Vademecum (Red Book)
2007–2009, including value-added tax. Total costs of
pharmacological treatment will be calculated by multiply-
ing the price per milligram by the daily dose in milligrams
and the number of days receiving such treatment. Costs
derived from the use of health-related services will be cal-
culated considering the SOIKOS unit costs database (25).
Indirect costs will be calculated considering the days under
sick leave and multiplying them by the minimum daily
wage in Spain for 2007–2009. Finally, total costs are going
to be calculated by adding direct and indirect costs.
In Spain, the National Healthcare Service (NHS) is
financed by the general taxes levied by the state. In the
municipalities where the study is carried out, it is admin-
istered by the autonomous government of Catalonia.
Medical visits and hospital admissions are fully covered
by the NHS. Medications prescribed are fully covered for
retired persons, and partially for those still employed. Sick
leave requires a physician's authorization, and patients
unable to work continue receiving most of their salary.
When performing cost-utility analyses, two or more ther-
apeutical options are compared in order to determine
which one is the best for maximizing the benefits in light
of the available resources [25,26]. This is achieved by cal-
culating the relationship between the costs of a given
intervention (e.g. A) and its consequences, expressed in
QALYs, compared with another (e.g. B). This relative
value is called incremental cost-utility ratio (ICUR), and it
expresses the relationship between the costs and effects of
one intervention compared with another.
As the duration of the study is only 12 months, neither
costs nor outcomes are subject to discounting [26]. Treat-
ment costs during 12 months follow-up will be modelled
by a multivariate gamma regression with a log link.
Gamma modelling has been suggested as a suitable choice
for analysing cost data, taking into account the skewing of
the distribution of the cost data [27,28]. QALYs gained in
the first and last six months after the beginning of the pro-
gram will be approximated by measuring the area under
the curve (Figure 1).
In the Figure 1, d0–6 is the incremental treatment effect on
change in EQ-5D utility score for the first 6 months and
d6–12the incremental treatment effect on change in EQ-5D
utility score for the last 6 months. These incremental treat-
ment effects will be estimated using multivariate ordinary
least squares regressions, adjusting for baseline differ-
ences among treatment groups. The covariates included in
the models will be: age, gender, years of education,
employment and marital status, baseline FIQ and EQ-5D
utility scores, and type of medication prescribed. To
address uncertainty in the ICUR sampling distribution,
non-parametric bootstrapping with five thousand replica-
tions will be carried out for each treatment comparison
[29].
Discussion
FM is a chronic illness that seriously alters the well-being
of patients [1-3,30]. One of the main expected contribu-
tions of the present project is that we will have the oppor-
tunity to assess not only whether a multimodal psycho-
educational program is feasible in primary health care,
but also whether it is more cost-effective than the usual
care provided for FM in this context.
Although FM has an irregular course that causes oscilla-
tions in the patients' quality of life, the random assign-
ment of the participants to the conditions will minimize
the differences not produced by the intervention. Baseline
comparisons between groups will permit detection of pos-
sible pre-treatment differences.
Formulas for calculating the QALYs gained in the first and  last six months after the beginning of the program Figure 1
Formulas for calculating the QALYs gained in the first and 
last six months after the beginning of the program.
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In our opinion, the application of the program in PC
entails a low outlay because nursing personnel may be
trained to develop the program, as in other recent educa-
tional programs developed for a number of chronic ill-
nesses [31,32].
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